
CAS 154397-77-0
:2-[3-[N-[1-Amidinopiperidin-3(S)-ylmethyl]carbamoyl]-N-cyclopropyl-2(S)-(2-naphthylsulfonamido)propionamido]acetic acid
Description:
The chemical substance known as 2-[3-[N-[1-Amidinopiperidin-3(S)-ylmethyl]carbamoyl]-N-cyclopropyl-2(S)-(2-naphthylsulfonamido)propionamido]acetic acid, with the CAS number 154397-77-0, is a complex organic compound characterized by its intricate structure, which includes multiple functional groups such as amides and sulfonamides. This compound features a piperidine ring, which contributes to its potential biological activity, and a naphthyl group that may enhance its lipophilicity and interaction with biological targets. The presence of the amidine functional group suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals. Its acetic acid moiety indicates that it may exhibit acidic properties, influencing its solubility and reactivity. Overall, this compound's unique structural features may provide insights into its pharmacological properties, making it a subject of interest in drug discovery and development. However, specific biological activities and applications would require further investigation through empirical studies.
Formula:C26H34N6O6S
InChI:InChI=1/C26H34N6O6S/c27-26(28)31-11-3-4-17(15-31)14-29-23(33)13-22(25(36)32(16-24(34)35)20-8-9-20)30-39(37,38)21-10-7-18-5-1-2-6-19(18)12-21/h1-2,5-7,10,12,17,20,22,30H,3-4,8-9,11,13-16H2,(H3,27,28)(H,29,33)(H,34,35)/t17?,22-/m0/s1
SMILES:c1ccc2cc(ccc2c1)S(=O)(=O)N[C@@H](CC(=NCC1CCCN(C1)C(=N)N)O)C(=O)N(CC(=O)O)C1CC1
Synonyms:- Napsagatran
- Ro-46-6240/010(monoH2O)
- Ro-46-6240
- N-[N4-[1-Amidinopiperidin-3(S)-ylmethyl]-N2-(2-naphthylsulfonyl)-L-asparaginyl]-(N-cyclopropyl)-glycine
- N-[(1-carbamimidoylpiperidin-3-yl)methyl]-N~2~-(naphthalen-2-ylsulfonyl)-L-asparaginyl-N-cyclopropylglycine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
Napsagatran
CAS:<p>Napsagatran is a human, activated, orally bioavailable, small molecule that acts as an oral thromboplastin inhibitor. It is metabolized by esterases to form the active drug napsagatran etexilate. Napsagatran inhibits the activity of heparin-induced thrombocytopenia (HIT) and has been shown to be effective in clinical studies. The pharmacokinetic properties of napsagatran have been characterized in humans using a pharmacokinetic study design with a two-way crossover design. A kinetic study was carried out using flow system analysis to determine the time course of plasma concentrations following administration of napsagatran etexilate.</p>Formula:C26H34N6O6SPurity:Min. 95%Molecular weight:558.65 g/mol
